Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

Bibliographic Details
Main Authors:	Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Format:	Online
Language:	English
Published:	Public Library of Science 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580068/

Similar Items

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
by: Schiavon, Gaia, et al.
Published: (2012)

Reintroduction of Imatinib in GIST
by: Reid, T.
Published: (2013)

Imatinib treatment for gastrointestinal stromal tumour (GIST)
by: Lopes, Lisandro F, et al.
Published: (2010)

Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
by: Sako, Hiroyuki, et al.
Published: (2014)

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate
by: Mohiuddin, Kamran, et al.
Published: (2007)

Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
by: Cauchi, C., et al.
Published: (2011)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
by: Revheim, Mona-Elisabeth, et al.
Published: (2014)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
by: Sumin Tang, et al.
Published: (2017-04-01)

Subcapsular Liver Hematoma in Metastatic GIST Complicating Imatinib (Gleevec) Therapy
by: Shankar, Sridhar
Published: (2015)

Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
by: Wasif, Komal, et al.
Published: (2016)

A GIST or not a GIST? That is the question
by: Chrysanthos, Nikolaos, et al.
Published: (2014)

Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy
by: Da Riva, Luca, et al.
Published: (2011)

Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
by: Wu, Ting-Jung, et al.
Published: (2006)

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
by: Rutkowski, Piotr, et al.
Published: (2012)

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
by: Blesius, Aurore, et al.
Published: (2011)

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
by: Joensuu, H, et al.
Published: (2011)

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
by: Seidel, Christoph, et al.
Published: (2012)

Genomic Subtypes of GISTs for Stratifying Patient Response to Sunitinib following Imatinib Resistance: A Pooled Analysis and Systematic Review
by: Siyuan Tan, et al.
Published: (2018-01-01)

Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
by: Falkenhorst, Johanna, et al.
Published: (2016)

CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib
by: Tian, Guang-Ang, et al.
Published: (2016)

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
by: Adenis, A., et al.
Published: (2014)

Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction
by: Berney, Christophe R.
Published: (2015)

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
by: Mahadevan, Daruka, et al.
Published: (2014)

Clinical and therapeutic considerations of GIST
by: Gheorghe, M, et al.
Published: (2014)

Serum Natrium Determines Outcome of Treatment of Advanced GIST with Imatinib: A Retrospective Study of 80 Patients from a Single Institution
by: Aggerholm-Pedersen, Ninna, et al.
Published: (2011)

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
by: Duffaud, Florence, et al.
Published: (2012)

Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
by: Revheim, Mona-Elisabeth, et al.
Published: (2013)

Comparison of the Long-Term Risk of Recurrence and Other Clinical Outcomes in GIST Patients Receiving Imatinib as Adjuvant Therapy—A Retrospective Chart Extract-Based Approach
by: Conley, Anthony Paul, et al.
Published: (2012)

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)
by: Spitaleri, Gianluca, et al.
Published: (2015)

Experiences and perspectives on the GIST patient journey
by: Macdonald, Nancy, et al.
Published: (2012)

The radiology of gastrointestinal stromal tumours (GIST)
by: Michael King, D
Published: (2005)

Cell tracking in cardiac repair: what to image and how to image
by: Ruggiero, Alessandro, et al.
Published: (2011)

Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group
by: Kalkmann, Janine, et al.
Published: (2012)

Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible?
by: Kim, Ki-Han, et al.
Published: (2012)

Erratum for “Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group”
by: Kalkmann, Janine, et al.
Published: (2013)

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
by: Nannini, Margherita, et al.
Published: (2014)

Gastrointestinal stromal tumors (GISTs) of the stomach: a multicenter, retrospective study of curatively resected gastric GISTs
by: Kim, In-Hwan, et al.
Published: (2014)

Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
by: Pantaleo, Maria A, et al.
Published: (2015)

Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia
by: Bitencourt, Roberta, et al.
Published: (2011)

Status of adjuvant endocrine therapy for breast cancer
by: Schiavon, Gaia, et al.
Published: (2014)